Percutaneous radiofrequency ablation of renal tumors: Technique, complications, and outcomes

被引:69
作者
Ahrar, K
Matin, S
Wood, CG
Wallace, MJ
Gupta, S
Madoff, DC
Rao, S
Tannir, NM
Jonasch, E
Pisters, LL
Rozner, MA
Kennamer, DL
Hicks, ME
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Diagnost Radiol, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA
[4] Univ Texas, MD Anderson Canc Ctr, Dept Anesthesiol & Cardiol, Houston, TX 77030 USA
关键词
D O I
10.1097/01.RVI.0000153589.10908.5F
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PURPOSE: To report the safety, technical success, and effectiveness of percutaneous radiofrequency (RF) ablation for renal tumors. MATERIALS AND METHODS: The authors retrospectively reviewed the medical records and imaging studies of 29 consecutive patients (18 men, 11 women; mean age, 65 +/- 2.62 years) with 30 renal tumors (mean diameter, 3.5 +/- 0.24 cm) who underwent percutaneous RF ablation at their institution from September 2001 to March 2004. All procedures were performed with computed tomography guidance with general anesthesia, and all patients were admitted to the hospital for overnight observation. Technical success, complications, and their management were recorded. Technique effectiveness was assessed by imaging and clinical follow up. RESULTS: Overall, 88 overlapping ablations were performed (mean, 2.6 +/- 0.16 ablations per tumor per session) in 34 sessions. There were four major complications (12%). Three patients had gross hematuria and urinary obstruction, all were successfully treated. One patient had persistent anterior abdominal wall weakness. There were also two minor complications (6%) without significant clinical sequelae. One patient had gross hematuria which resolved spontaneously, another patient had transient paresthesia of the anterior abdominal wall. There were no significant changes in renal function after RF ablation. The intent of RF ablation was eradication of the primary tumor in 27 patients and treatment of gross hematuria in the other two. Technical success was achieved in all cases. Follow-up images were available for 26 patients. The primary tumor was completely ablated in 23 of 24 patients (96%) in whom eradication of the primary tumor was attempted (follow up period: mean, 10 months, median 7 months). The two patients treated for hematuria remained asymptomatic for 6 and 27 months each. CONCLUSION: Percutaneous RF ablation for renal tumors is safe and well tolerated. High technical success rates are expected. Early reports of the technique's effectiveness are promising.
引用
收藏
页码:679 / 688
页数:10
相关论文
共 23 条
[1]   Efficacy of nephron-sparing surgery for renal cell carcinoma: Analysis based on the new 1997 tumor-node-metastasis staging system [J].
Belldegrun, A ;
Tsui, KH ;
deKernion, JB ;
Smith, RB .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) :2868-2875
[2]   Permanent flank bulge is a consequence of flank incision for radical nephrectomy in one half of patients [J].
Chatterjee, S ;
Nam, R ;
Fleshner, N ;
Klotz, L .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2004, 22 (01) :36-39
[3]   Lumbosacral radiculopathy following radiofrequency ablation therapy [J].
Coskun, DJ ;
Gilchrist, J ;
Dupuy, D .
MUSCLE & NERVE, 2003, 28 (06) :754-756
[4]   Paranephric water instillation: A technique to prevent bowel injury during percutaneous renal radiofrequency ablation [J].
Farrell, MA ;
Charboneau, JW ;
Callstrom, MR ;
Reading, CC ;
Engen, DE ;
Blute, ML .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2003, 181 (05) :1315-1317
[5]   Imaging-guided radiofrequency ablation of solid renal tumors [J].
Farrell, MA ;
Charboneau, WJ ;
DiMarco, DS ;
Chow, GK ;
Zincke, H ;
Callstrom, MR ;
Lewis, BD ;
Lee, RA ;
Reading, CC .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2003, 180 (06) :1509-1513
[6]   Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup [J].
Fergany, AF ;
Hafez, KS ;
Novick, AC .
JOURNAL OF UROLOGY, 2000, 163 (02) :442-445
[7]   Cytoreductive nephrectomy in patients with metastatic renal cancer: A combined analysis [J].
Flanigan, RC ;
Mickisch, G ;
Sylvester, R ;
Tangen, C ;
Van Poppel, H ;
Crawford, ED .
JOURNAL OF UROLOGY, 2004, 171 (03) :1071-1076
[8]   Renal cell carcinoma: Clinical experience and technical success with radio-frequency ablation of 42 tumors [J].
Gervais, DA ;
McGovern, F ;
Arellano, RS ;
McDougal, WS ;
Mueller, PR .
RADIOLOGY, 2003, 226 (02) :417-424
[9]   Percutaneous radiofrequency tissue ablation: Does perfusion-mediated tissue cooling limit coagulation necrosis? [J].
Goldberg, SN ;
Hahn, PF ;
Tanabe, KK ;
Mueller, PR ;
Schima, W ;
Athanasoulis, CA ;
Compton, CC ;
Solbiati, L ;
Gazelle, GS .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 1998, 9 (01) :101-111
[10]   Image-guided tumor ablation: Proposal for standardization of terms and reporting criteria [J].
Goldberg, SN ;
Charboneau, JW ;
Dodd, GD ;
Dupuy, DE ;
Gervais, DA ;
Gillams, AR ;
Kane, RA ;
Lee, FT ;
Livraghi, T ;
McGahan, JP ;
Rhim, H ;
Silverman, SG ;
Solbiati, L ;
Vogl, TJ ;
Wood, BJ .
RADIOLOGY, 2003, 228 (02) :335-345